- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Policy Recommendations Michigan
2020-21 Improvements and Recommendations
At the moment, Michigan’s COVID emergency measures remain in place; they include curbside pickup and telehealth services for certifications and renewals. Michigan’s population of registered patients saw narrow growth of just over 2% in 2020-2021.
This year, the state of Michigan recalled about 64,000-pounds of cannabis products in November after customers complained of allergic reactions, chest pains, flu-like symptoms, and other negative health outcomes. All of the products recalled were tested by a single laboratory between August and November. After a second round of tests, 26% of the products recalled were found to contain levels of yeast and mold that would be dangerous for individuals with weak immune systems or lung conditions. 68% of the products that failed the second test were intended for medical cannabis patients. The laboratory that failed to competently test these products for dangerous adulterants and put patients in danger challenged the state in court and won. The judge presiding over the case ordered Michigan’s regulators to release the contaminated product back onto the market. Though the toxicity of the products will be recorded in the state product tracking system, patients have no way of viewing this system for themselves.
For 2022, Michigan lawmakers must abandon plans to restrict caregiver growing of cannabis. This is a critical policy for patients that allows them to keep the cost of their own treatments down, a right they have greatly benefited from for many years. Lawmakers and regulators should also look at other policies that make medical cannabis more affordable for patients like financial hardship waivers and discounts for administrative fees. The state must also prioritize codifying additional patient rights like employment and housing protections. Finally, regulators should review the state’s product recall processes to ensure there is an impartial recall laboratory run by the state, and that future recalls are not overly broad, pulling unaffected products from the shelf and creating a supply problem for patients.
Share